Literature DB >> 3132512

Human interferon-gamma protects rhesus monkeys against sporozoite-induced Plasmodium cynomolgi malaria infection.

S K Puri1, R K Maheshwari, G P Dutta, R M Friedman, M M Dhar.   

Abstract

Earlier we reported that prophylactic treatment with recombinant human interferon gamma (rHuIFN-gamma) for a prolonged duration completely suppressed experimental infection with Plasmodium cynomolgi B sporozoites in rhesus monkeys. We now show that reducing the rHuIFN-gamma treatment to three administrations given close to the time (on days -1, 0, and +1) of infection was sufficient for complete protection. Animals initially protected by rHuIFN-gamma treatment are susceptible to reinfection. Studies are in progress to understand the precise mechanism of protection afforded by HuIFN-gamma against sporozoite-induced malaria infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132512     DOI: 10.1089/jir.1988.8.201

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  6 in total

Review 1.  Animal models in interferon research: some current trends.

Authors:  H Schellekens
Journal:  Experientia       Date:  1989-06-15

2.  The role of cytokines in malaria infection.

Authors:  R K Maheshwari
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

4.  Chloroquine paradox may cause more damage than help fight COVID-19.

Authors:  Anuj Sharma
Journal:  Microbes Infect       Date:  2020-04-17       Impact factor: 2.700

Review 5.  Parasite-Host Interaction and Pathophysiology Studies of the Human Relapsing Malarias Plasmodium vivax and Plasmodium ovale Infections in Non-Human Primates.

Authors:  Erica M Pasini; Clemens H M Kocken
Journal:  Front Cell Infect Microbiol       Date:  2021-02-17       Impact factor: 5.293

6.  Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections.

Authors:  Erika van den Bogaart; Al-Badawi A Talha; Masja Straetemans; Pètra F Mens; Emily R Adams; Martin P Grobusch; Bakri Y M Nour; Henk D F H Schallig
Journal:  BMC Immunol       Date:  2014-05-01       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.